HIV/AIDS surveillance and service data analysis in the Republic of Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR)

Post Date

March 31st 2009

Application Due Date

May 29th 2009

Funding Opportunity Number

CDC-RFA-PS09-981

CFDA Number(s)

93.067

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

1

Eligibility Categories

Other

Eligible applicants Eligible applicants that can apply for this funding opportunity appear below: • Public, non-profit organizations; • Private, non-profit organizations; • For-profit organizations; • Small, minority, and women-owned businesses; • Universities; • Colleges; • Research institutions; • Hospitals; • Community-based organizations; • Faith-based organizations; • Federally recognized Indian tribal Governments; • Indian tribes; • Indian tribal organizations; • U.S. State and local Governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau); • Political subdivisions of U.S. States (in consultation with States); A Bona Fide Agent is an agency/organization identified by a state as eligible to submit an application under the State's eligibility in lieu of a State application. If applying as a bona fide agent of a State or local Government, a letter from the State or local Government as documentation of the status is required. Place this documentation behind the first page of the application form.

Funding

• Estimated Total Funding:

  $300000

• Award Range:

  $300000 - $300000

Grant Description

The purpose of this announcement is to provide a funding mechanism in the Republic of Haiti to: • Carry out periodic Antenatal Clinic (ANC) sero-surveys in order to follow the trend of both the HIV/AIDS and syphilis epidemics among pregnant women attending these clinics in the Republic of Haiti. • Perform HIV drug resistance threshold study to evaluate the extent of transmitted HIV drug resistance in sero-sentinel surveillance sites. • Perform periodic triangulation of data in order to demonstrate program impact, identify areas for improvement, direct new programs and enhance existing programs as well as help direct policy changes . • Perform cohort studies to capture data on key aspects of patient care and treatment in a selected number of ART sites of the PEPFAR network at baseline, 6 months, and then yearly in order to assess the performance of the ART sites regarding delivery of treatment.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  CDC Procurement and Grants Office
  Technical Information Management
  Phone 770-488-2700

• Agency Mailing Address:

  PGO Technical Information Management

• Agency Email Address:

  PGOTIM@cdc.gov